Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Meningioma 1 (MN1) contains two sets of CAG repeats.
Showing 10 out of 41 products:
The data obtained show that normal cells consistently express low levels of MN1 transcript. In contrast, high levels of MN1 expression are present in 47% of patients with normal karyotype and in all cases with inv (zeige INVS Antikörper)(16).
Patients with t(12;22)/MN1-EVT6 oncogene (zeige RAB1A Antikörper), are frequently associated with myeloid neoplasms, poor response to chemotherapy, and inferior outcome.
MN1 gene expression in acute myeloid leukemia (zeige BCL11A Antikörper).
MN1 deletion is associated with Craniofacial Abnormalities.
Chromosome 22q12.1 microdeletions involving the MN1 gene confirm it as a candidate gene for cleft palate.
MLL1 and DOT1L (zeige DOT1L Antikörper) cooperate with meningioma-1 to induce acute myeloid leukemia (zeige BCL11A Antikörper).
genotype-phenotype correlation among our patients and those previously reported with overlapping 22q12 deletions, we identified a 560 kb critical region containing the MN1 gene that is implicated in human cleft palate formation
these results suggest that deregulated MN1 expression contributes to the pathogenesis of pediatric B-ALL.
identified potential driver mutations in NF2 (neurofibromatosis type 2) and MN1 (meningioma 1).
cotransduction of an activated HOX (zeige MSH2 Antikörper) gene (NUP98HOXD13) with MN1 induces a serially transplantable acute myeloid leukemia (zeige BCL11A Antikörper) (AML (zeige RUNX1 Antikörper)).
Meningioma 1 (MN1) contains two sets of CAG repeats. It is disrupted by a balanced translocation (4\\;22) in a meningioma, and its inactivation may contribute to meningioma 32 pathogenesis.
meningioma (translocation balanced)
, meningioma chromosome region 1
, probable tumor suppressor protein MN1